AOD-9604

Peptide Name: AOD-9604
 
Chemical Name: L-Tyrosyl-L-leucyl-L-arginyl-L-isoleucyl-L-valyl-L-glutaminyl-L-cysteinyl-L-arginyl-L-seryl-L-valyl-L-glutamyl-L-glycyl-L-seryl-L-cysteinyl-L-glycyl-L-phenylalanine cyclic (7->14)-disulfide CAS Number: 221231-10-3
 
*Please note Acetic Acid is needed to Reconstitute AOD
 
DESCRIPTION
AOD-9604 is a synthetic peptide fragment derived from the C-terminal end of Human Growth Hormone (hGH), specifically representing amino acids 177 to 191 with an additional tyrosine residue. Unlike the full-length hormone, AOD-9604 is designed to isolate the lipolytic (fat-burning) properties of hGH without inducing unwanted growth-related side effects or impacting insulin sensitivity. Research primarily focuses on its ability to stimulate the metabolism of adipose tissue and its potential therapeutic application in musculoskeletal repair and regenerative medicine.
Targeted Fat Loss: Research suggests it mimics the natural hormone's ability to trigger fat release from obese fat cells.
Non-Diabetogenic: Studies indicate that it does not increase blood sugar levels or affect insulin receptors.
Chondrogenic Potential: Laboratory investigations show promising results in enhancing the repair of damaged cartilage and alleviating symptoms of osteoarthritis.
Recovery Acceleration: Preliminary data indicates potential for improving muscle and tendon recovery following injury.
 
KIT INCLUDES:
1x Peptide Vial
1x 10ml Sterile Water
1x Reconstitution Kit
 
REGULATORY NOTICES
SAHPRA DISCLAIMER This product has not been evaluated by the South African Health Products Regulatory Authority (SAHPRA). It is not intended to diagnose, treat, cure, or prevent any disease.
RESEARCH USE ONLY 
 
SCIENTIFIC STUDIES
Safety and Tolerability of AOD-9604 in Humans: https://pubmed.ncbi.nlm.nih.gov/11713213/
The Effects of AOD-9604 on Fat Oxidation and Weight Loss: https://pubmed.ncbi.nlm.nih.gov/11146367/
AOD-9604 and Cartilage Regeneration in Osteoarthritis Models: https://pmc.ncbi.nlm.nih.gov/articles/PMC4214552/
Clinical Trial Summary of hGH Fragment 177-191: https://pubmed.ncbi.nlm.nih.gov/11713213/